Mon, August 8, 2022
Fri, August 5, 2022
Thu, August 4, 2022

Justin Kim Downgraded (BCRX) to Hold on, Aug 5th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. kim-downgraded-bcrx-to-hold-on-aug-5th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Justin Kim of Oppenheimer, Downgraded "BioCryst Pharmaceuticals, Inc." (BCRX) to Hold on, Aug 5th, 2022.

Justin has made no other calls on BCRX in the last 4 months.



There are 2 other peers that have a rating on BCRX. Out of the 2 peers that are also analyzing BCRX, all agree with Justin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $14 on, Tuesday, April 12th, 2022
  • Tazeen Ahmad of "B of A Securities" Downgraded from Strong Buy to Hold and Held Target at $14 on, Monday, April 11th, 2022